News Daily News Year in Review: Pulsed-Field Ablation Again Tops Heart Rhythm News Todd Neale December 24, 2025
News Daily News Etripamil Nasal Spray Gains FDA Approval for Acute Paroxysmal SVT Todd Neale December 15, 2025
News Daily News LAAO May Be an Option for Anticoagulated AF Patients With Breakthrough Stroke Todd Neale September 30, 2025
News Daily News DOACs Reduce Stroke, Increase Bleeding in ICH Survivors With AF Todd Neale March 06, 2025
News Daily News Lower-Dose Edoxaban May Be an Option After Age 80: ENGAGE AF-TIMI 48 Analysis Todd Neale July 12, 2024
News Daily News Diltiazem and DOAC Interaction Increases Bleeding Risk in AF L.A. McKeown April 18, 2024
News Daily News Low Bleeding Profile With Asundexian Seen in Pooled Analysis L.A. McKeown February 13, 2024
News Daily News BMI Mostly Doesn’t Impact DOACs, Except Maybe at the Extremes Todd Neale February 02, 2024
News Daily News CRT-D Offers Persistent Survival Benefit in Long-term RAFT Results Todd Neale January 23, 2024
News Daily News New AF Guideline Emphasizes Early Rhythm Control, Elevates Ablation and LAAO Todd Neale November 30, 2023
News Daily News Ischemic Stroke After LAA Closure May Be Less Severe Than on DOACs Michael O'Riordan November 27, 2023
News Daily News PCI Doesn’t Cut Arrhythmias in Severe LV Dysfunction: REVIVED-BCIS2 Analysis Todd Neale August 14, 2023
News Daily News Off-label DOAC Dosing Tied to Worse Adherence, More Discontinuation Todd Neale June 14, 2023
News Daily News Borderline Cost-effectiveness for SGLT2 Inhibitors in HFpEF Todd Neale March 15, 2023
News Daily News LAAO Tops Oral Anticoagulation for AF in Women and Men: Medicare Analysis Todd Neale February 24, 2023
News Daily News Tricuspid Regurgitation After AF Diagnosis Is Common, Worsens Outcomes Yael L. Maxwell December 06, 2022
News Daily News Slight Risk of Interstitial Lung Disease Seen With Certain DOACs Todd Neale November 23, 2022
News Daily News Apixaban Again Linked to Less Bleeding in AF Patients Michael O'Riordan October 31, 2022
News Daily News Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest Michael O'Riordan October 20, 2022